Cargando…

Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers

A cross-sectional prospective cohort study including 1026 heifers administered tulathromycin due to high risk of clinical signs of bovine respiratory disease (BRD), measured poor association between BRD clinical outcomes and results of bacterial culture and tulathromycin susceptibility from BRD isol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarchet, Jeffrey J., Pollreisz, John P., Bechtol, David T., Blanding, Mitchell R., Saltman, Roger L., Taube, Patrick C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830659/ https://www.ncbi.nlm.nih.gov/pubmed/35143504 http://dx.doi.org/10.1371/journal.pone.0247213

Ejemplares similares

Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves
por: Mzyk, Danielle A., et al.
Publicado: (2019)

Tulathromycin metaphylaxis increases nasopharyngeal isolation of multidrug resistant Mannheimia haemolytica in stocker heifers
por: Crosby, William B., et al.
Publicado: (2023)

Tulathromycin and Diclazuril Lack Efficacy against Theileria haneyi, but Tulathromycin Is Not Associated with Adverse Clinical Effects in Six Treated Adult Horses
por: Onzere, Cynthia K., et al.
Publicado: (2023)

Gallic Acid Potentiates the Antimicrobial Activity of Tulathromycin Against Two Key Bovine Respiratory Disease (BRD) Causing-Pathogens
por: Rajamanickam, Karthic, et al.
Publicado: (2019)

Comparison of two distinct arrival and treatment programs for bovine respiratory disease in high-risk feeder cattle entering a feedlot
por: Pollreisz, John P, et al.
Publicado: (2022)

Efficacy of Tulathromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia
por: Rutenberg, D., et al.
Publicado: (2017)

Evaluation of Biological Equivalence for Generic Tulathromycin Injections in Cattle
por: Kang, JeongWoo, et al.
Publicado: (2023)

Lycopene Attenuates Tulathromycin and Diclofenac Sodium-Induced Cardiotoxicity in Mice
por: Abdel-Daim, Mohamed M., et al.
Publicado: (2018)

Case Study: Control of bovine respiratory disease in dairy calves with tulathromycin and effect on calf health and performance from 0 to 4 months of age
por: Hill, T.M., et al.
Publicado: (2017)

Immuno-modulating properties of Tulathromycin in porcine monocyte-derived macrophages infected with porcine reproductive and respiratory syndrome virus
por: Desmonts de Lamache, D., et al.
Publicado: (2019)

Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices
por: Rivera, J Daniel, et al.
Publicado: (2019)

Pharmacokinetics of tulathromycin in pregnant ewes (Ovis aries) challenged with Campylobacter jejuni
por: Yaeger, Michael, et al.
Publicado: (2021)

Susceptibility to tulathromycin in Mannheimia haemolytica isolated from feedlot cattle over a 3-year period
por: Alexander, Trevor W., et al.
Publicado: (2013)

Lung Ultrasonography and Clinical Follow-Up Evaluations in Fattening Bulls Affected by Bovine Respiratory Disease (BRD) during the Restocking Period and after Tulathromycin and Ketoprofen Treatment
por: Fiore, Enrico, et al.
Publicado: (2022)

Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental Mycoplasma bovis infection in calves
por: Bartram, David J., et al.
Publicado: (2016)

The Anti-Nociceptive Potential of Tulathromycin against Chemically and Thermally Induced Pain in Mice
por: Elbadawy, Mohamed, et al.
Publicado: (2021)

Metagenomic Analysis of the Fecal Archaeome in Suckling Piglets Following Perinatal Tulathromycin Metaphylaxis
por: Zeineldin, Mohamed, et al.
Publicado: (2021)

Chemotherapeutic Strategies with Valnemulin, Tilmicosin, and Tulathromycin to Control Mycoplasma hyopneumoniae Infection in Pigs
por: Stingelin, Giovani Marco, et al.
Publicado: (2022)

Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin
por: Pereira, R. V., et al.
Publicado: (2020)

Effect of Tulathromycin on Colonization Resistance, Antimicrobial Resistance, and Virulence of Human Gut Microbiota in Chemostats
por: Hao, Haihong, et al.
Publicado: (2016)

Effects of treatment with enrofloxacin or tulathromycin on fecal microbiota composition and genetic function of dairy calves
por: Foditsch, Carla, et al.
Publicado: (2019)

In vitro Elution of Penicillin, Ampicillin, Tetracycline, Tulathromycin, and Florfenicol From Plaster of Paris Beads
por: Merkatoris, Paul, et al.
Publicado: (2020)

Synovial fluid pharmacokinetics of tulathromycin, gamithromycin and florfenicol after a single subcutaneous dose in cattle
por: Jones, Meredyth L, et al.
Publicado: (2015)

Assessment of Draxxin(®) (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi
por: Silva, Marta G., et al.
Publicado: (2018)

Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model
por: Zhou, Qiaoyi, et al.
Publicado: (2017)

Investigating Effects of Tulathromycin Metaphylaxis on the Fecal Resistome and Microbiome of Commercial Feedlot Cattle Early in the Feeding Period
por: Doster, Enrique, et al.
Publicado: (2018)

Negligible Impact of Perinatal Tulathromycin Metaphylaxis on the Developmental Dynamics of Fecal Microbiota and Their Accompanying Antimicrobial Resistome in Piglets
por: Zeineldin, Mohamed M., et al.
Publicado: (2019)

Antibiotic treatment in feedlot cattle: a longitudinal study of the effect of oxytetracycline and tulathromycin on the fecal and nasopharyngeal microbiota
por: Holman, Devin B., et al.
Publicado: (2019)

Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against Actinobacillus pleuropneumoniae in a Porcine Tissue Cage Infection Model
por: Yao, Lihua, et al.
Publicado: (2022)

Intensive antibiotic treatment of sows with parenteral crystalline ceftiofur and tulathromycin alters the composition of the nasal microbiota of their offspring
por: Bonillo-Lopez, Laura, et al.
Publicado: (2023)

Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model
por: Zhao, Yongda, et al.
Publicado: (2018)

Influence of therapeutic use of feedgrade tetracyclines in combination with tulathromycin metaphylaxis on animal health and performance of Holstein steer calves
por: Szasz, Josh I, et al.
Publicado: (2018)

Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection
por: Zhou, Yu-Feng, et al.
Publicado: (2017)

Tulathromycin treatment does not affect bacterial dissemination or clearance of Brucella melitensis 16M following experimental infection of goats
por: Boggiatto, Paola M., et al.
Publicado: (2019)

Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin
por: Foster, Derek M., et al.
Publicado: (2016)

In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
por: Guo, Li-li, et al.
Publicado: (2021)

Correction: Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin
por: Foster, Derek M., et al.
Publicado: (2016)

Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants
por: Xia, Xirui, et al.
Publicado: (2022)

Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach
por: Lin, Zhoumeng, et al.
Publicado: (2016)

A single LC‐MS/MS validated method for tulathromycin quantification in plasma, seminal plasma, and urine to be applied in a pharmacokinetic study in bull
por: Barbarossa, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_meodfel99avq5kpe3pb72tu7bh